Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Zi-min Sun"'
Autor:
Xiao-hui Zhang, Jing Chen, Ming-Zhe Han, He Huang, Er-lie Jiang, Ming Jiang, Yong-rong Lai, Dai-hong Liu, Qi-Fa Liu, Ting Liu, Han-yun Ren, Yong-Ping Song, Zi-min Sun, Xiao-wen Tang, Jian-min Wang, De-pei Wu, Lan-ping Xu, Xi Zhang, Dao-bin Zhou, Xiao-jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-20 (2021)
Abstract The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) facilitated the standardization o
Externí odkaz:
https://doaj.org/article/0888f470080e4c5f9d96fc5f09be3e84
Autor:
Yao Chen, Wei-Jun Fu, Lan-Ping Xu, Han-Yun Ren, Yong-Rong Lai, Dai-Hong Liu, Lin Liu, Zi-Min Sun, Yuan-Bin Wu, Xin Wang, Ling-Hui Xia, Ming Jiang, Tong-Lin Hu, Ding-Ming Wan, Xiao-Jun Huang, Yuan-Yuan Ji
Publikováno v:
Chinese Medical Journal, Vol 132, Iss 15, Pp 1765-1772 (2019)
Abstract. Background:. Allogeneic stem-cell transplantation (SCT) is a well-established immunotherapeutic strategy for multiple myeloma (MM) with a potent and often sustained graft-vs.-myeloma effect. This multicenter investigation aimed to analyze t
Externí odkaz:
https://doaj.org/article/844de11142d44cfe9717e73c554b3ed1
Autor:
Jian-Qiu Wu, Yong-Ping Song, Li-Ping Su, Ming-Zhi Zhang, Wei Li, Yu Hu, Xiao-Hong Zhang, Yu-Huan Gao, Zuo-Xing Niu, Ru Feng, Wei Wang, Jie-Wen Peng, Xiao-Lin Li, Xue-Nong Ouyang, Chang-Ping Wu, Wei-Jing Zhang, Yun Zeng, Zhen Xiao, Ying-Min Liang, Yong-Zhi Zhuang, Ji-Shi Wang, Zi-Min Sun, Hai Bai, Tong-Jian Cui, Ji-Feng Feng
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 15, Pp 1767-1775 (2018)
Background: Prospective real-life data on the safety and effectiveness of rituximab in Chinese patients with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) are limited. This real-world study aimed to evaluate long-term safety and e
Externí odkaz:
https://doaj.org/article/8af0a1edd6c84c3eb8c97c68936a8b1f
Autor:
Bo-lin Tang, Hui-Zhi Yang, Yong-Sheng Han, Kai-Yang Ding, Xin Liu, Wen Yao, Xin-Bing Wang, Liang-Quan Geng, Hui-Lan Liu, Zi-Min Sun, Juan Tong, Wei-Bo Zhu, Zu-Yi Wang
Publikováno v:
Journal of Hematology & Oncology, Vol 3, Iss 1, p 51 (2010)
Abstract Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for severe aplastic anemia (SAA). However, graft failure and graft-versus-host disease (GVHD) are major causes of the early morbidity in Allo
Externí odkaz:
https://doaj.org/article/7022e9ed840149bc803ce903d7a581f3
Autor:
Xiao‐Dong Mo, Shen‐Da Hong, Yan‐Li Zhao, Er‐Lie Jiang, Jing Chen, Yang Xu, Zi‐Min Sun, Wei‐Jie Zhang, Qi‐Fa Liu, Dai‐Hong Liu, Ding‐Ming Wan, Wen‐Jian Mo, Han‐Yun Ren, Ting Yang, He Huang, Xi Zhang, Xiao‐Ning Wang, Xian‐Min Song, Su‐Jun Gao, Xin Wang, Yi Chen, Bing Xu, Ming Jiang, Xiao‐Bing Huang, Xin Li, Hong‐Yu Zhang, Hong‐Tao Wang, Zhao Wang, Ting Niu, Ji‐Shi Wang, Ling‐Hui Xia, Xiao‐Dan Liu, Fei Li, Fang Zhou, Tao Lang, Jiong Hu, Sui‐Jing Wu, Xiao‐Jun Huang
Publikováno v:
American Journal of Hematology. 97:458-469
Steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is one of the leading causes of early mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We investigated the efficacy, safety, prognostic factors, and optima
Autor:
Xin-xin Cao, Jie Jin, Cheng-cheng Fu, Shu-hua Yi, Wei-li Zhao, Zi-min Sun, Wei Yang, Deng-ju Li, Guo-hui Cui, Jian-da Hu, Ting Liu, Yong-ping Song, Bing Xu, Zun-min Zhu, Wei Xu, Ming-zhi Zhang, Ya-min Tian, Bin Zhang, Ren-bin Zhao, Dao-bin Zhou
Publikováno v:
EClinicalMedicine. 52
Orelabrutinib is a novel, small molecule, selective irreversible Bruton tyrosine kinase inhibitor. The purpose of this study was to evaluate the efficacy and safety of orelabrutinib in patients with relapsed or refractory Waldenström's macroglobulin
Autor:
Lan-Ping Xu, Dao-Pei Lu, De-Pei Wu, Er-Lie Jiang, Dai-Hong Liu, He Huang, Zi-Min Sun, Nai-Nong Li, Qi-Fa Liu, Xi Zhang, Yong-Rong Lai, Yong-Ping Song, Xian-Min Song, Si-Xi Liu, Yi-Cheng Zhang, Cheng-Juan Luo, Ling-Hui Xia, Ting Niu, Yu Yu, Xiao-Hui Zhang, Xiao-Wen Tang, Yi Luo, Xiao-Jun Huang
Publikováno v:
Transplantation and Cellular Therapy. 29:136.e1-136.e7
Between 2020 and 2021, 31,525 hematopoietic stem cell transplantations (HSCTs) were reported to the Chinese Blood and Marrow Transplantation Registry Group throughout mainland China. In this report, we describe the activity and current trends for HSC
Autor:
Guifang Li, Zi-min Sun, Liangquan Geng, Xiang Wan, Xiaoyu Zhu, Xuhan Zhang, Juan Tong, Wen Yao, Kaidi Song, Ping Qiang, Lei Zhang, Bao-ling Tang, Shiyang Zhang, Huilan Liu
Background:Juvenile myelomonocytic leukemia (JMML) is a rare hematological malignancy in young children and can only be cured through the allogeneic stem cell transplantation. Procedure:We have retrospectively analyzed the outcomes of nine childr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d5c3c5532abd86daa1381803f9302ce
https://doi.org/10.22541/au.164865156.60793079/v1
https://doi.org/10.22541/au.164865156.60793079/v1
Autor:
Qian-Wen, Xu, Hui, Xu, Lei, Xue, Li, Wang, Xu-Han, Zhang, Kai-di, Song, Wen, Yao, Xiang, Wan, Juan, Tong, Hui-Lan, Liu, Xin, Liu, Xiao-Yu, Zhu, Zi-Min, Sun, Xing-Bing, Wang
Publikováno v:
Transfusion and Apheresis Science. 61:103473
We reviewed the outcomes of 77 episodes of CD19 CAR-T therapy in 67 patients with B cell hematological malignancies from October 2016 to January 2020. Factors related to the grade of cytokine release syndrome (CRS) were explored by multivariate analy
Autor:
Ting Yang, Xiangfeng Tang, Ke Huang, Weiping Zhang, Rong-Mu Luo, Shun-Qing Wang, Chun Chen, Chengjuan Luo, Yuan Sun, Xianmin Song, Shaoyan Hu, Yi-Ping Zhu, Ming Zhou, Zi-Min Sun, Jiong Hu, Xia Qin, Jing Chen
Publikováno v:
Annals of hematology. 100(9)
With the dramatic improvements in outcomes following alternative donor hematopoietic stem cell transplantation (HSCT), interest in the use of alternative donors in severe aplastic anemia (SAA) is increasing. We conducted a multicenter prospective stu